Sar1b mutant mice recapitulate gastrointestinal abnormalities associated with chylomicron retention disease

Autor: Emile Levy, Nickolas Auclair, Lena Ahmarani, Jean-François Beaulieu, Noël Peretti, Nathalie Patey, Schohraya Spahis, Alain T. Sané
Přispěvatelé: CarMeN, laboratoire, Centre de recherche du CHU Sainte-Justine / Research Center of the Sainte-Justine University Hospital [Montreal, Canada], Université de Montréal (UdeM)-CHU Sainte Justine [Montréal], Université de Sherbrooke (UdeS), Cardiovasculaire, métabolisme, diabétologie et nutrition (CarMeN), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Hospices Civils de Lyon (HCL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Centre de recherche du CHU Sainte-Justine [Montreal]
Jazyk: angličtina
Rok vydání: 2021
Předmět:
0301 basic medicine
[SDV]Life Sciences [q-bio]
CRD
Chylomicron retention disease

AMPK
AMP-Activated protein kinase

030204 cardiovascular system & hematology
MTTP
Microsomal triglyceride transfer protein

medicine.disease_cause
Biochemistry
pAMPK
Phospho AMPK

Microsomal triglyceride transfer protein
Hypobetalipoproteinemias
0302 clinical medicine
Endocrinology
lipid metabolism
fatty acid β-oxidation
Mutation
TG
triglyceride

embryonic lethality
CM
Chylomicron

chylomicron
SAR1B
[SDV] Life Sciences [q-bio]
pACC
Phospho ACC

dietary fat
Lipogenesis
CHOL
Cholesterol

Chylomicron retention disease
Research Article
medicine.medical_specialty
Sar1b
chylomicron retention disease
QD415-436
Biology
CPT1
Carnitine palmitoyl transferase

lipogenesis
03 medical and health sciences
Malabsorption Syndromes
Internal medicine
medicine
Genetically modified animal
CRISPR/Cas9
COPII
Coat protein complex II

ACADL
Acyl-CoA dehydrogenase and long chain

ACC
Acetyl CoA carboxylase

Lipid metabolism
Cell Biology
medicine.disease
gene defects
030104 developmental biology
biology.protein
Chylomicron
Zdroj: Journal of Lipid Research
Journal of Lipid Research, 2021, 62, pp.100085. ⟨10.1016/j.jlr.2021.100085⟩
Journal of Lipid Research, American Society for Biochemistry and Molecular Biology, 2021, 62, pp.100085. ⟨10.1016/j.jlr.2021.100085⟩
Journal of Lipid Research, Vol 62, Iss, Pp 100085-(2021)
ISSN: 0022-2275
DOI: 10.1016/j.jlr.2021.100085
Popis: International audience; Chylomicron retention disease (CRD) is an autosomal recessive disorder associated with biallelic Sar1b mutations leading to defects in intracellular chylomicron (CM) trafficking and secretion. To date, a direct cause-effect relationship between CRD and Sar1b mutation has not been established, but genetically modified animal models provide an opportunity to elucidate unrecognized aspects of these mutations. To examine the physiological role and molecular mechanisms of Sar1b function, we generated mice expressing either a targeted deletion or mutation of human Sar1b using the CRISPR-Cas9 system. We found that deletion or mutation of Sar1b in mice resulted in late-gestation lethality of homozygous embryos. Moreover, compared with WT mice, heterozygotes carrying a single disrupted Sar1b allele displayed lower plasma levels of triglycerides, total cholesterol, and HDL-cholesterol, along with reduced CM secretion following gastric lipid gavage. Similarly, decreased expression of apolipoprotein B and microsomal triglyceride transfer protein was observed in correlation with the accumulation of mucosal lipids. Inefficient fat absorption in heterozygotes was confirmed via an increase in fecal lipid excretion. Furthermore, genetically modified Sar1b affected intestinal lipid homeostasis as demonstrated by enhanced fatty acid β-oxidation and diminished lipogenesis through the modulation of transcription factors. This is the first reported mammalian animal model with human Sar1b genetic defects, which reproduces some of the characteristic CRD features and provides a direct cause-effect demonstration.
Databáze: OpenAIRE